VANGUARD GROUP INC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Sage Therapeutics Inc (SAGE)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Sage Therapeutics Inc Common Stock
Symbol: SAGE
Shares outstanding: 61.2M shares
Disclosed Ownership: 4.84M shares
Ownership: 7.9%
Form type: SCHEDULE 13G/A
Date filed: 1/31/2025, 09:55 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	7.9%	4.84M	0	37.1K	Ashley Grim	Head of Global Fund Administration